{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T21:32:53Z","timestamp":1783632773577,"version":"3.55.0"},"reference-count":38,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T00:00:00Z","timestamp":1643328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Aim: To assess the outcomes of 737 consecutive patients with DCIS, with particular attention to the type of recurrences, other malignancies and causes of deaths. Material and Methods: A retrospective analysis of 737 consecutive DCIS patients treated in one institution in the years 1996\u20132011 was carried out. The cumulative recurrence risk, DFS, OS depending on the method of treatment (mastectomy, breast-conserving treatment (BCT), breast-conserving surgery (BCS)) and cause of death were assessed. Results: Sixty-six recurrences (42% DCIS, 58% invasive) were reported: 61 in the breast and 5 outside the breast. The cumulative recurrence risk after a 15-year observation after mastectomy, BCT and BCS was 3.2%, 19.5% and 31.2%, respectively (p &lt; 0.001). The 15-year DFS after mastectomy, BCT and BCS was 72%, 65% and 48%, respectively (p &lt; 0.001). The 15-year OS after mastectomy, BCT and BCS was 75%, 83% and 70%, respectively (p = 0.329). Deaths due to DCIS progression were reported in four (0.5%) of the overall patients and in 10.5% of patients with invasive recurrences. The majority of deaths were linked to the age of the patients or other diseases, including other neoplasms, but not DCIS. Conclusions: The highest number of recurrences was reported in patients after BCS, despite the fact that it was the lowest-risk group. In total, 79% of local recurrences were true recurrences and 58% were invasive recurrences. Local recurrences were effectively treated without an influence on the OS. The percentage of deaths due to DCIS was low and mainly concerned patients with locoregional and distant failure.<\/jats:p>","DOI":"10.3390\/cancers14030669","type":"journal-article","created":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T01:41:59Z","timestamp":1643420519000},"page":"669","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Type of Recurrence, Cause of Death and Second Neoplasms among 737 Patients with Ductal Carcinoma In Situ of the Breast\u201415-Year Follow-Up"],"prefix":"10.3390","volume":"14","author":[{"given":"Anna","family":"Niwi\u0144ska","sequence":"first","affiliation":[{"name":"Department of Breast Cancer and Reconstructive Surgery, Maria Sklodowska-Curie National Research Institute of Oncology, Roentgen 5 Str., 02-784 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u0142","family":"Kunkiel","sequence":"additional","affiliation":[{"name":"Department of Breast Cancer and Reconstructive Surgery, Maria Sklodowska-Curie National Research Institute of Oncology, Roentgen 5 Str., 02-784 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,1,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/jncimonographs\/lgq027","article-title":"Epidemiology of ductal carcinoma in situ","volume":"41","author":"Kerlikowske","year":"2010","journal-title":"J. Natl. Cancer Inst. Monogr."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s10549-012-1975-y","article-title":"Increased diagnosis and detection rates of carcinoma in situ of the breast","volume":"133","author":"Glover","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ctrv.2017.03.009","article-title":"Current treatment trends and the need for better predictive tools in the management of ductal carcinoma in situ of the breast","volume":"55","author":"Turnbull","year":"2017","journal-title":"Cancer Treat. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1093\/jnci\/djh164","article-title":"Ductal carcinoma in situ, complexities and challenges","volume":"96","author":"Leonard","year":"2004","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10549-005-9101-z","article-title":"The natural history of ductal carcinoma in situ of the breast: A review","volume":"97","author":"Erbas","year":"2005","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3389\/fonc.2017.00248","article-title":"Ductal Carcinoma In Situ Biology, Biomarkers, and Diagnosis","volume":"7","author":"Gorringe","year":"2017","journal-title":"Front. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1200\/JCO.2014.57.9029","article-title":"RTOG 9804, A Prospective Randomized Trial for Good-Risk Ductal Carcinoma In Situ Comparing Radiotherapy With Observation","volume":"33","author":"McCormick","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3938","DOI":"10.1200\/JCO.2015.60.8588","article-title":"Surgical Excision Without Radiation for Ductal Carcinoma in Situ of the Breast: 12-Year Results From the ECOG-ACRIN E5194 Study","volume":"33","author":"Solin","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/tbj.12368","article-title":"Treatment selection for patients with ductal carcinoma in situ (DCIS) of the breast using the University of Southern California\/Van Nuys (USC\/VNPI) Prognostic Index","volume":"21","author":"Silverstein","year":"2015","journal-title":"Breast J."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1245\/s10434-012-2412-5","article-title":"Twenty-Year Outcomes after Breast-Conserving Surgery and Definitive Radiotherapy for Mammographically Detected Ductal Carcinoma In Situ","volume":"19","author":"Vicini","year":"2012","journal-title":"Ann. Surg. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/jnci\/djr027","article-title":"Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trias for DCIS","volume":"103","author":"Wapnir","year":"2011","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"4054","DOI":"10.1200\/JCO.2013.49.5077","article-title":"Breast-conserving treatment with or without radiotherapy in ductal carcinoma in situ: 15-year recurrence rates and outcome after recurrence, from EORTC 10853 randomized chase III trial","volume":"31","author":"Donker","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0002-9610(03)00265-4","article-title":"The University of Southern California\/VanNuys Prognostic Index for ductal carcinoma in situ of the breast","volume":"186","author":"Silverstein","year":"2003","journal-title":"Am. J. Surg"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1097\/00000478-200008000-00003","article-title":"Intraductal Carcinoma of the Breast","volume":"24","author":"Goldstein","year":"2000","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.radonc.2014.06.011","article-title":"Radiotherapy in DCIS, an underestimated benefit?","volume":"112","author":"Cutuli","year":"2014","journal-title":"Radiother. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1093\/jnci\/djq101","article-title":"Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis","volume":"102","author":"Kerlikowske","year":"2010","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s10549-013-2455-8","article-title":"Can we select individuals with low risk ductal carcinoma in situ (DCIS)? A population-based outcomes analysis","volume":"138","author":"Rakovitch","year":"2013","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"4264","DOI":"10.1245\/s10434-019-07693-1","article-title":"Impact of Age on Locoregional and Distant Recurrence After Mastectomy for Ductal Carcinoma In Situ With or Without Microinvasion","volume":"26","author":"Mamtani","year":"2019","journal-title":"Ann. Surg. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-015-1904-7","article-title":"Long-term outcomes of ductal carcinoma in situ of the breast: A systematic review, meta-analysis and meta-regression analysis","volume":"15","author":"Stuart","year":"2015","journal-title":"BMC Cancer"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/COC.0000000000000102","article-title":"Ductal carcinoma in situ of the breast: Evaluating the role of radiation therapy in the management and attempts to identify low-risk patients","volume":"38","author":"Shah","year":"2015","journal-title":"Am. J. Clin. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1245\/s10434-010-1335-2","article-title":"Analyzing the Risk of Recurrence after Mastectomy for DCIS: A New Use for the USC\/Van Nuys Prognostic Index","volume":"18","author":"Kelley","year":"2010","journal-title":"Ann. Surg. Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1200\/JCO.2001.19.8.2263","article-title":"Risk Factors for Recurrence and Metastasis After Breast-Conserving Therapy for Ductal Carcinoma-In-Situ: Analysis of European Organization for Research and Treatment of Cancer Trial 10853","volume":"19","author":"Bijker","year":"2001","journal-title":"J. Clin. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1093\/annonc\/mdx308","article-title":"De-escalating and escalating treatments for early-stage breast cancer: The St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017","volume":"28","author":"Curigliano","year":"2017","journal-title":"Ann. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1200\/JCO.2014.56.2595","article-title":"Effect of Radiotherapy After Breast-Conserving Surgery for Ductal Carcinoma in Situ: 20 Years Follow-Up in the Randomized SweDCIS Trial","volume":"32","author":"Garmo","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1470-2045(10)70266-7","article-title":"Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: Long-term results from the UK\/ANZ DCIS trial","volume":"12","author":"Cuzick","year":"2011","journal-title":"Lancet Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Early Breast Cancer Trialists\u2019 Collaborative Group (EBCTCG), Correa, C., McGale, P., Taylor, C., Wang, Y., Clarke, M., Davies, C., Peto, R., Bijker, N., and Solin, L. (2010). Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. J. Natl. Cancer Inst. Monogr., 41, 162\u2013177.","DOI":"10.1093\/jncimonographs\/lgq039"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Goodwin, A., Parker, S., Ghersi, D., and Wilcken, N. (2013). Post-operative radiotherapy for ductal carcinoma in situ of the breast. Cochrane Database Syst. Rev., CD000563.","DOI":"10.1002\/14651858.CD000563.pub7"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Garg, P.K., Jakhetiya, A., Pandey, R., Chishi, N., and Pandey, D. (2017). Adjuvant radiotherapy versus observation following lumpectomy in ductal carcinoma in-situ: A meta-analysis of randomized controlled trials. Breast J., 233\u2013239.","DOI":"10.1111\/tbj.12889"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s10549-019-05428-0","article-title":"Long-term outcomes of breast-conserving therapy for women with ductal carcinoma in situ","volume":"178","author":"Warren","year":"2019","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/(SICI)1097-0142(19990201)85:3<616::AID-CNCR12>3.0.CO;2-7","article-title":"Predictors of local recurrence after treatment of ductal carcinoma in situ: A meta-analysis","volume":"85","author":"Boyages","year":"1999","journal-title":"Cancer"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e2017124","DOI":"10.1001\/jamanetworkopen.2020.17124","article-title":"Association of a Diagnosis of Ductal Carcinoma In Situ With Death From Breast Can-cer","volume":"3","author":"Giannakeas","year":"2020","journal-title":"JAMA Network Open."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1001\/jamaoncol.2015.2510","article-title":"Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ","volume":"1","author":"Narod","year":"2015","journal-title":"JAMA Oncol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"djv263","DOI":"10.1093\/jnci\/djv263","article-title":"Trends in Treatment Patterns and Outcomes for Ductal Carcinoma In Situ","volume":"107","author":"Worni","year":"2015","journal-title":"JNCI: J. Natl. Cancer Inst."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1002\/ijc.30413","article-title":"Cause-specific mortality in women with breast cancer in situ","volume":"140","author":"He","year":"2017","journal-title":"Int. J. Cancer"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1200\/JCO.2015.65.1869","article-title":"Patient Prognostic Score and Associations With Survival Improvement Offered by Radiotherapy After Breast-Conserving Surgery for Ductal Carcinoma In Situ: A Population-Based Longitudinal Cohort Study","volume":"34","author":"Sagara","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1097\/SLA.0000000000002239","article-title":"Cause-specific Mortality in a Population-based Cohort of 9799 Women Treated for Ductal Carcinoma In Situ","volume":"267","author":"Elshof","year":"2018","journal-title":"Ann. Surg."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1748-717X-2-28","article-title":"Breast-conserving surgery with or without radiotherapy in women with ductal carcinoma in situ: A meta-analysis of randomized trials","volume":"2","author":"Viani","year":"2007","journal-title":"Radiat. Oncol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/s41416-020-01152-5","article-title":"Pathological features of 11,337 patients with primary ductal carcinoma in situ (DCIS) and subsequent events: Results from the UK Sloane Project","volume":"124","author":"Shaaban","year":"2020","journal-title":"Br. J. Cancer"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/14\/3\/669\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:10:04Z","timestamp":1760134204000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/14\/3\/669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,28]]},"references-count":38,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,2]]}},"alternative-id":["cancers14030669"],"URL":"https:\/\/doi.org\/10.3390\/cancers14030669","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,28]]}}}